Obes Surg26 Jan 2024
Post-bariatric patients experiencing weight regain benefitted more from a 16-week low-calorie DASH diet than a low-calorie diet alone. The DASH group showed superior improvements in weight loss, body mass index, and fat mass reduction, compared to the control group. Both interventions led to significant reductions…
Surg Obes Relat Dis24 Jan 2024
Routine extended (30 days) chemoprophylaxis for laparoscopic sleeve gastrectomy (SG) may decrease portomesenteric vein thrombosis (PMVT) rates. A study of 8,864 SG patients revealed that implementing routine extended chemoprophylaxis significantly reduced PMVT occurrences, but at the cost of a higher postoperative bleeding rate. The majority…
Obes Surg23 Jan 2024
The study investigated the metabolic changes and physiological factors mediating the effects of Roux-en-Y gastric bypass (RYGB) surgery in obese patients. Results showed that insulin concentrations decreased significantly after the surgery, along with improvements in weight loss and insulin sensitivity. Additionally, triglycerides, remnant cholesterol, lactate,…
Obes Surg23 Jan 2024
The CDC's recent statements on obesity causing metabolic syndrome and attributing it to individual behavior are contested. Bariatric surgery outcomes challenge the direct link between obesity and diabetes suggested by the CDC. The rise in diabetes rates from 2004 to 2012 contradicts behavior-based explanations. The…
Obes Surg23 Jan 2024
Regardless of diet, Roux-en-Y gastric bypass (RYGB) led to significant reductions in body weight, fat mass, and lean mass. RYGB and high-fat diet (HFD) independently affected bone mineral density and vitamin D levels. HFD after RYGB posed a significant health risk, impairing improvements to dyslipidemia,…
BMC Surg22 Jan 2024
A retrospective study compared the outcomes of Roux-en-Y gastric bypass and fundoplication in patients with obesity and gastroesophageal reflux disease (GERD). Ninety-five patients with a BMI ≥35 underwent either procedure. Both groups saw an improvement in GERD symptoms and overall quality of life. There were…
Ann Surg21 Jan 2024
Metabolic surgery has been found to facilitate the resolution of nonalcoholic steatohepatitis (NASH) and improve fibrosis in patients with obesity. A study comparing the histologic outcomes of metabolic surgery versus nonsurgical care in individuals with fibrotic NASH revealed that half of the surgical patients achieved…
BMC Surg20 Jan 2024
The study aimed to assess the impact of mood disorders on weight loss outcomes in patients undergoing bariatric surgery. Data from 775 patients were analyzed, out of which 38.1% had pre-existing mood disorder diagnoses. Both groups experienced significant reductions in postoperative body mass index, with…
Surg Endosc19 Jan 2024
Patients with end-stage renal disease (ESRD) on dialysis who underwent bariatric surgery experienced longer operative times and increased postoperative complications compared to those without renal disease. The study, analyzing data from the 2015-2020 MBSAQIP database, found that laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric…
Surg Endosc19 Jan 2024
Researchers investigated the feasibility of single-port sleeve gastrectomy (SPSG) by introducing a routine gastric suspension technique. Analyzing 171 patients, they compared SPSG to multiple-port sleeve gastrectomy (MPSG) and found no significant differences in preoperative and perioperative parameters, complications, or total weight loss percentages. SPSG demonstrated…